Correction: Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study

Affiliations

• ¹ Department of Medicine (Medical Genetics), University of Washington, Seattle, WA, USA. hartmr@uw.edu.
• ² Clinical Sequencing Exploratory Research Coordinating Center, University of Washington, Seattle, WA, USA. hartmr@uw.edu.
• ³ Social and Behavioral Research Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
• ⁴ Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
• ⁵ Harvard Medical School, Boston, MA, USA.
• ⁶ Department of Medicine (Medical Genetics), University of Washington, Seattle, WA, USA.
• ⁷ Clinical Sequencing Exploratory Research Coordinating Center, University of Washington, Seattle, WA, USA.
• ⁸ Department of Pediatrics, Oncology Section, Baylor College of Medicine, Houston, TX, USA.
• ⁹ Division of Human Genetics, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
• ¹⁰ HudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.
• ¹¹ Department of Pediatrics, University of Louisville, Louisville, KY, USA.
• ¹² Division of Genomic Diagnostics, Department of Pathology and Laboratory Medicine, The Children's Hospital, Philadelphia, PA, USA.
• ¹³ Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• ¹⁴ Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
• ¹⁵ Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.
• ¹⁶ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
• ¹⁷ Department of Medical Genetics, Kaiser Permanente Northwest, Portland, OR, USA.
• ¹⁸ Center for Health Research, Kaiser Permanente Northwest, Portland, OR, USA.
• ¹⁹ Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
• ²⁰ Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, TX, USA.
• ²¹ Laboratory for Molecular Medicine, Partners HealthCare, Cambridge, MA, USA.
• ²² Broad Institute of MIT and Harvard, Cambridge, MA, USA.
• ²³ Knight Diagnostic Laboratories, Oregon Health Science University, Portland, OR, USA.
• ²⁴ VA Boston Healthcare System, Boston, MA, USA.
• ²⁵ Department of Pediatrics and Seattle Children's Research Institute, University of Washington, Seattle, WA, USA.
• ²⁶ Department of Pharmacy, University of Washington, Seattle, WA, USA.
• ²⁷ Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
• ²⁸ Partners Personalized Medicine, Boston, MA, USA.
• ²⁹ Division of Genomic Medicine, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA. hindorffl@mail.nih.gov.